Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab.
The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab.
Report by Thomasl.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
